BlankHarveySmithJ. G.Jr.PothF. J.Jr.ZaiasNardo: Griseofulvin for the Systemic Treatment of Dermatomycoses. Journal of American Medical Association16: 2168–2173 (Dec. 19) 1959.
2.
BrownDor W.Jr.: The Clinical Use of T.O.E. in E.E.N.T. Practice. American Medical Association Archives of Otolaryngology70: 5: 588–592 (Nov.) 1959.
3.
GodlowskiZ. Z.: Hormonal Influence of the Enzymatic Mechanism of Allergy. Transactions American Academy of Ophthalmology and Otolaryngology61: 6: 728–745 (Nov.-Dec.) 1957.
4.
GodlowskiZ. Z.: Hormones Related to Allergy. Transactions American Academy of Ophthalmology and Otolaryngology62: 6: 835–863 (Nov.-Dec.) 1958.
5.
HanselF. K.: The Use of Staphylococcus Toxoid and the Extracts of Pathogenic Molds in Otolaryngology and Ophthalmology. Transactions American Academy of Ophthalmology and Otolaryngology267–271 (Mar.-Apr.) 1952.
6.
HazenE.BrownR: Discovery of Nystatin. Monographs on Therapy2: 69, 1957.
7.
McCuistianC. H.Jr.LawlisM. G.GonzalezB. B.: Toxicological Studies and Effectiveness of Griseofulvin in Dermatomycoses. Journal of American Medical Association171: 16: 2174–2180 (Dec. 19) 1959.
8.
RinkelH. J.: A Course in Allergy. University of Texas Post Graduate School of Medicine and Baylor University College of Medicine, Texas Medical Center, Houston, Texas, February 9, 1956.